Who, in their right mind, ever thought that Botox would be of such an insanely high value?
The company that makes Botox, Allergan, has been bought by pharmaceutical giant Actavis for… wait for it… $66 billion.
Brent Saunders, the CEO and president of Actavis, is excited.
We will create a top 10 pharmaceutical company, one generating more than $23 billion annually.
I would be excited. too.
Though the deal was unanimously approved by the boards of each company, it will need a green light from the business’ shareholders, and company officials will spend coming months seeking various regulatory approvals.
Check out USA Today
